We chose to activate canonical NFκB/p65 signaling with tumor necrosis factor alpha (TNFα), a potent ligand for canonical NFκB/p65 signaling known to promote proliferation, migration, and primary tumor growth of TNBC24,25. The gene discussed is TNF; the disease is neoplasm.